OMX Ventures

What is OMX Ventures?

OMX Ventures is an investment firm that concentrates its efforts in sectors like BioTech, AgroTech, CleanTech, HealthTech & Fitness, Medical Devices & Hospital Services, and Healthcare & Wellness. They are deeply involved in nurturing and growing companies that stand on the frontiers of biology and technology, with a particular focus on those utilizing Bio-Tools, Data, and Artificial Intelligence to pioneer significant breakthroughs.

OMX Ventures applies a 'technology-first' philosophy, priding themselves on taking groundbreaking discoveries and transforming them into scalable biotech companies.

The firm seeks to invest in what they believe to be tomorrow's transformative companies at the inception of a biology revolution that promises to overhaul our lives.

They focus on early-stage investments, including Seed and Series A rounds, with a minimum investment size of $500,000 and a maximum of $15,000,000, while their investment sweet spot is $7,800,000. Their portfolio showcases active involvement in advancing sectors such as mental health therapeutics, women's health, antibody engineering, synthetic genomes, precision metabolomics, and molecular biology.

OMX Ventures manages assets under their control worth $150,000,000 and maintains a keen interest in fostering novel classes of therapeutics, harnessing microbiomics, engineering antibodies for improved treatments, pioneering genome writing, and developing next-gen diagnostic tools.

Furthermore, they feature innovative companies like Delix, Freya, Mythic, Constructive Bio, Matterworks, and VedaBio in their portfolio, which represent the leading edge of their respective fields covering therapeutics, synthetic biology, bio-tools, diagnostics, and more.

What they say:

We are a venture firm exploring innovative intersections of scientific fields.

What we look for: We invest at the convergence of life sciences and deep technology.